ACAD FY 2016 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+28311.5% YoY

Gross Profit

$13M74.6% margin

Operating Income

-$273M-1574.1% margin

Net Income

-$271M-1565.9% margin

EPS (Diluted)

$-2.34

Cash Flow

Operating Cash Flow

-$210M

Free Cash Flow

-$220M

Stock-Based Comp.

$55M

Balance Sheet

Total Assets

$561M

Total Liabilities

$43M

Stockholders' Equity

$518M

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$61,000	+28311.5%
Gross Profit	$13M	-$76M	+116.9%
Operating Income	-$273M	-$165M	-65.7%
Net Income	-$271M	-$164M	-65.0%